Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Abrau-Durso's additional share issue to be held at ₽275 per share

3/4/25 ABRD

Moscow Exchange summarized the results of trading in February

3/3/25 MOEX

5Post leased its first purpose-built warehouse facility

3/3/25 X5

Aeroflot brought its dividend policy to a unified approach for state-owned companies

3/3/25 AFLT

Magnit Market began to open PVZ in the distribution centers of Magnit

3/3/25 MGNT

Severstal reports for 2024 by RAS

3/3/25 CHMF

Weekend trading volume on SPB Exchange grew to ₽1.52 billion

3/3/25 SPBE

DEC reported for 2024 by RAS

3/3/25 DVEC

TMK reports for 2024 by IFRS

3/3/25 TRMK

Volume of first weekend trading on Moscow Exchange amounted to ₽10.1 billion

3/3/25 MOEX